A research team led by Berkeley Lab has developed a technique that could accelerate the design of artificial antibodies for biomedical applications – from sensing technologies that detect and neutralize infectious viruses and bacteria to the early detection of Alzheimer’s. “We can now readily build populations of rugged synthetic materials that can be engineered to recognize a potential pathogen,” said Zuckermann. “It is a shining example of biomimetic nanoscience.”